Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-up.

A DezellusS MirallieF LeperlierB SautereyP-E BouetA DessaintS DurosA S GremeauM-A Mouret-ReynierL M DurandL VenatP De BlayM RobertT FreourM CamponeA Blanc-LapierreV Bordes

Published in: Breast (Edinburgh, Scotland) (2024)

Tamoxifen-COS protocols appear to be feasible before adjuvant or NAC treatment in young BC patients and efficient in terms of oocyte yield.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
early stage
prognostic factors
transcription factor
peritoneal dialysis
middle aged